In contrast, TMB and overall neoantigen load did not correlate with prognosis, suggesting that TP53 neoantigens, rather than TMB or neoantigen load, play a key role in the prognosis of HCC patients [71]. This evidence concerns the gene TP53 and hepatocellular carcinoma.